From Wikidoc - Reading time: 3 min
|
Amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Amyloidosis natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Amyloidosis natural history, complications and prognosis |
|
FDA on Amyloidosis natural history, complications and prognosis |
|
CDC on Amyloidosis natural history, complications and prognosis |
|
Amyloidosis natural history, complications and prognosis in the news |
|
Blogs on Amyloidosis natural history, complications and prognosis |
|
Risk calculators and risk factors for Amyloidosis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
In amyloidosis, insoluble fibrils of amyloid are deposited in organs, causing organ dysfunction and eventually death. Patients with amyloidosis may eventually suffer from heart failure, nephrotic syndrome, hepatomegaly and peripheral neuropathy. In primary amyloidosis, the survival rate depends upon the type of organ involvement and the hematological response to treatment. In AL amyloidosis, untreated individuals have the worst prognosis. In this group of patients, the median survival is one to two years.
In patients with amyloidosis, the most frequent complications include:[3]